Ignite Creation Date:
2024-05-06 @ 1:47 AM
Last Modification Date:
2024-10-26 @ 11:10 AM
Study NCT ID:
NCT01907009
Status:
TERMINATED
Last Update Posted:
2023-04-19
First Post:
2013-07-22
Brief Title:
A Phase II Study Evaluating Intravenous Melphalan With Autologous Whole Blood Stem Cell Transplantation Over Three Cycles In Patients With Castration-Resistant Prostate Cancer MEL-CAP
Sponsor:
Barts The London NHS Trust
Organization:
Barts The London NHS Trust
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Castrate Resistant Prostate Cancer |
Keywords: